Investigational Drug Service, Department of Pharmacy (Investigational Product)

Rochester, New York 14642

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed